Novozymes A/S B buy RudolfL
Start price
11.09.20
/
50%
€55.52
Target price
04.11.21
€63.00
Performance (%)
18.70%
End price
05.11.21
€65.90
Summary
This prediction ended on 05.11.21 with a price of €65.90. The BUY prediction by RudolfL finished with a performance of 18.70%. Dividends of €0.71 are taken into consideration when calculating the performance. RudolfL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novozymes A/S B | -3.063% | -3.063% | -16.011% | 1.196% |
| iShares Core DAX® | -4.932% | -11.977% | -3.667% | 45.798% |
| iShares Nasdaq 100 | -2.634% | -2.218% | 14.638% | 78.685% |
| iShares Nikkei 225® | -4.733% | -10.900% | 19.738% | 45.866% |
| iShares S&P 500 | -2.544% | -3.540% | 9.339% | 58.518% |
According to RudolfL what are the pros and cons of Novozymes A/S B for the foreseeable future?
Pros
Market Leader or Top 3
Higher EBIT margin than peer group
positive Cash Flow expected
ROE higher than 15% per year
Cons
Revenue decline/stagnation expected
Comments by RudolfL for this prediction
In the thread Novozymes A/s Nam. B diskutieren
In the thread Trading Novozymes A/s Nam. B
Die von RudolfL gewählte maximale Laufzeit wurde überschritten
Stopped prediction by RudolfL for Novozymes A/S B
Novozymes A/S B
Start price
Target price
Perf. (%)
€46.87
26.01.20
26.01.20
€53.00
13.08.20
13.08.20
5.33%
13.08.20
13.08.20
Market Leader or Top 3
Higher EBIT margin than peer group
positive Cash Flow expected
Revenue decline/stagnation expected
